Takis Formazione

Merry Christmas from Takis Biotech!Sent on 23 December 2020

Takis Biotech starting preclinical experimentation with COVID-19 vaccineSent on 17 March 2020

Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNAT Vaccine Candidates Designed Sent on 02 March 2020

Coronavirus vaccine: Takis Biotech on the frontline Sent on 17 February 2020

Takis/Evvivax announce the research activity for the development of a Vaccine against Wuhan Coronavirus 2019-nCoVSent on 27 January 2020

Takis & VITARES Formazione - Dott. Ersilia Fiscarelli - "I FUNGHI IN FIBROSI CISTICA"Sent on 13 December 2019

Takis second Biotech in Europe at EIT Health Catapult Final!Sent on 07 December 2019

European EIT Health Biotech Final: Forza Takis and Forza Italia!Sent on 30 November 2019

LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor ReductionSent on 25 September 2019

Takis Innovation and Health Technologies awarded in Lazio RegionSent on 16 July 2019

Takis Antibodies TraZimAb and Rever3mAb moving forward!Sent on 10 July 2019

Takis Biotech Research moving forward!Sent on 19 June 2019

TAKIS announces a collaboration partnership with TRIANNI for Human Therapeutic Antibody generationSent on 10 April 2019

Takis & VITARES Formazione - Dott. Marco Crescenzi - "Promuovere la Ricerca Scientifica del Lazio nel Pubblico e nel Privato: le Core facilities dell’ISS"Sent on 10 October 2018

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccinesSent on 29 September 2018

Incontra TAKIS al congresso FISV a Roma!Sent on 18 September 2018

Display #
Results 1 - 16 out of 16

Terms of use
Privacy
Ethical code
This email address is being protected from spambots. You need JavaScript enabled to view it.
Webmail